My PCOS Diary

Insulin Resistance and PCOS — Research and 3 Years of Inositol Experience

PCOS isn't just a reproductive condition. Learn how insulin resistance drives PCOS symptoms, why lean women aren't immune, and what the latest 2024–2025 research reveals.

Mar 15, 2026

When I was diagnosed with PCOS,

most of what my doctor told me was about my cycle, ovulation, and fertility.

Insulin barely came up.

But the more I read, the clearer it became: PCOS isn't primarily a reproductive condition.

It's a metabolic one.

What Is Insulin Resistance?

Insulin is a hormone that helps glucose from food enter your cells, where it can be used for energy or stored for later.

Insulin resistance is what happens when your cells stop responding to insulin the way they should — meaning it takes more and more insulin to process the same amount of glucose.

The pancreas compensates by producing even more insulin, and that state of chronically elevated insulin is called hyperinsulinemia.

Insulin Resistance Is Extremely Common in PCOS

Insulin resistance is one of the most prevalent metabolic abnormalities seen in PCOS. Depending on the study and population, estimates range from roughly 50 to 95% of women with PCOS — making it far more the rule than the exception. [1]

Importantly, this isn't limited to women who are overweight. Lean women with PCOS can also have insulin resistance. [1] [2]

That was true for me. Through my mid-twenties, I weighed around 50–52 kg — not overweight by any measure. But that didn't mean my metabolism was unaffected. Research showing that metabolic dysfunction can occur in non-obese women with PCOS helped me understand why my body was responding the way it was. [2]

The Relationship Between Insulin Resistance and Androgens

One of the reasons insulin resistance makes PCOS worse is its relationship with androgens.

In PCOS, high insulin levels can stimulate the ovaries to produce more androgens. And elevated androgens, in turn, can worsen insulin resistance and drive even more insulin secretion — a cycle that reinforces itself. [3] [4]

Latest Research — Shifting the Focus from Glucose to Insulin

For decades, the standard approach to metabolic dysfunction in PCOS has been glucose-centric — measuring blood sugar, checking HbA1c, watching for diabetes risk.

But recent research is pushing in a different direction. Some researchers now argue for a paradigm shift toward an insulin-centric model: rather than waiting for blood sugar to show abnormalities, the focus should move to insulin itself, earlier in the process. [5]

Going further, some recent reviews suggest that hyperinsulinemia may actually precede insulin resistance in some cases — meaning elevated insulin isn't just a downstream consequence, but potentially an earlier signal. [3]

The relationship between PCOS and insulin resistance isn't a simple one-way street. It may be complex and bidirectional. [2]

PCOS — Beyond Reproduction, Toward Metabolic Health

The 2023 International Evidence-Based PCOS Guideline explicitly frames PCOS as more than a reproductive condition — one that includes metabolic risk factors and requires broader assessment. [6]

Left unmanaged, insulin resistance in PCOS is associated with cardiovascular risk factors, subclinical cardiovascular disease, and over time, actual cardiovascular events. [1]

Understanding this changed how I thought about managing my PCOS. Getting my period back wasn't the only goal. Managing insulin was just as important — maybe more so.

Inositol — My Experience vs. What the Research Shows

I want to be clear about the difference between what I personally experienced and what the current research actually supports.

What I felt was this: the negative thoughts that used to dominate my mind started to lose their intensity. Before, they felt three-dimensional — elevated, protruding, demanding my attention. After starting inositol, they flattened out. They were still there, but they no longer pulled my focus the way they used to. A kind of quiet settled in, and with it, the aggression and negative emotions started to ease as well.

That's my personal experience, and I want to be honest about the context. At the time, I was dealing with a scalp that was oozing and flaking, layered on top of unprocessed stress and difficult memories. My mind was running hot in a negative direction. What I felt after starting inositol wasn't a mild improvement — it was a clear, noticeable shift. I'm not exaggerating. That's genuinely what happened.

However, compared to my personal experience, the current research is more cautious.

The strongest evidence for inositol in PCOS centers on insulin signaling, metabolic health, and menstrual and ovulatory outcomes. The 2023 International PCOS Guideline notes that inositol can be considered based on individual preferences and values, but overall, the evidence for clinical benefit remains limited. [6] A 2024 systematic review and meta-analysis found that while inositol shows some promise, the evidence is not yet conclusive. [7]

On the emotional side, research suggests possibilities but stops short of firm conclusions. Small clinical trials found that inositol reduced the frequency and severity of panic attacks and agoraphobia symptoms more than placebo [8], and another study reported similar improvements to fluvoxamine. [9] A 2014 meta-analysis found potential benefits for depression, particularly PMDD, but noted the small number of included studies as a significant limitation. [10]

So: inositol probably isn't irrelevant to mood and anxiety — but the research doesn't come close to confirming what I experienced in terms of intensity or form.

The most accurate way to frame it is this: what the research shows is that inositol has been studied in the context of PCOS, metabolic health, and some psychiatric conditions. What I'm describing is something separate — my own experience after more than three years of long-term use. The research provides context and possibility. My experience is a record of what actually happened to me. The two can overlap, but they're not the same thing.

How to Check for Insulin Resistance — HOMA-IR

One of the most commonly used tools for estimating insulin resistance is HOMA-IR:

HOMA-IR = (fasting glucose × fasting insulin) ÷ 405

It's calculated from a simple fasting blood draw. That said, reference ranges vary depending on the study and population, so a single number shouldn't be interpreted in isolation. How to read your results in context is something best done with your healthcare provider.

I'll cover how to interpret PCOS-related blood test results in more detail in a future post.

Bottom Line

Insulin resistance is one of the core mechanisms driving PCOS, and it can show up regardless of body weight. Blood sugar can look completely normal while insulin is already elevated. That elevated insulin feeds androgen production, which worsens insulin resistance — and the loop continues.

Managing PCOS means finding ways to interrupt that loop.

⚠️ Disclaimer
Everything on this blog is based on personal experience and publicly available research. This is not medical advice. Please consult your healthcare provider before making any changes to your treatment or lifestyle.

References

  1. Dubey et al. 2024 — Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
  1. Prosperi & Chiarelli 2025 — Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum
  1. Houston & Templeman 2025 — Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS
  1. Diamanti-Kandarakis & Dunaif 2012 — Insulin resistance and the polycystic ovary syndrome revisited
  1. Parker et al. 2025 — Recognizing the Role of Insulin Resistance in PCOS: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model
  1. Teede et al. 2023 — Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
  1. Fitz et al. 2024 — Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis
  1. Benjamin et al. 1995 — Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
  1. Palatnik et al. 2001 — Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder
  1. Mukai et al. 2014 — A meta-analysis of inositol for depression and anxiety disorders
 

You might also like